Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group
Pulczynski, Elisa J, Kuittinen, Outi, Erlanson, Martin, Hagberg, Hans, Fosså, Alexander, Eriksson, Mikael, Nordstrøm, Marie, Østenstad, Bjørn, Fluge, Øystein, Leppä, Sirpa, Fiirgaard, Bente, Bersvendsen, Hanne, Fagerli, Unn-Merete
Published in Haematologica (Roma) (01.04.2015)
Published in Haematologica (Roma) (01.04.2015)
Get full text
Journal Article
Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma
ABREY, Lauren E, BATCHELOR, Tracy T, NEUWELT, Edward A, O'NEILL, Brian Patrick, THIEL, Eckhard, SHENKIER, Tamara, GRAUS, Fransesc, VAN DEN BENT, Martin, SEYMOUR, John F, POORTMANS, Philip, ARMITAGE, James O, CAVALLI, Franco, FERRERI, Andrés J. M, GOSPODAROWICZ, Mary, PULCZYNSKI, Elisa J, ZUCCA, Emanuele, SMITH, Justine R, KORFEL, Agnieszka, SOUSSAIN, Carole, DEANGELIS, Lisa M
Published in Journal of clinical oncology (01.08.2005)
Published in Journal of clinical oncology (01.08.2005)
Get full text
Journal Article
The Danish National Chronic Lymphocytic Leukemia Registry
da Cunha-Bang, Caspar, Geisler, Christian Hartmann, Enggaard, Lisbeth, Poulsen, Christian Bjørn, de Nully Brown, Peter, Frederiksen, Henrik, Bergmann, Olav Jonas, Pulczynski, Elisa Jacobsen, Pedersen, Robert Schou, Nielsen, Linda Højberg, Christiansen, Ilse, Niemann, Carsten Utoft
Published in Clinical epidemiology (01.01.2016)
Published in Clinical epidemiology (01.01.2016)
Get full text
Journal Article
Little value of surveillance magnetic resonance imaging for primary CNS lymphomas in first remission: results from a Danish Multicentre Study
Mylam, Karen Juul, Michaelsen, Thomas Yssing, Hutchings, Martin, Jacobsen Pulczynski, Elisa, Pedersen, Lars Møller, Brændstrup, Peter, Gade, Inger Lise, Eberlein, Tobias Ramm, Gang, Anne Ortved, Bøgsted, Martin, Brown, Peter de Nully, El‐Galaly, Tarec Christoffer
Published in British journal of haematology (01.02.2017)
Published in British journal of haematology (01.02.2017)
Get full text
Journal Article
Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up
Pulczynski, Elisa Jacobsen, Simonsen, Mikkel Runason, Kuittinen, Outi, Fagerli, Unn-Merete, Erlanson, Martin, Fluge, Øystein, Leppä, Sirpa, Østenstad, Bjørn, Fosså, Alexander, Eriksson, Mikael, El-Galaly, Tarec, Kuitunen, Hanne, Papworth, Karin, Ljungqvist, Maria, Pedersen, Martin B, Pollari, Marjukka
Published in Haematologica (Roma) (01.07.2024)
Published in Haematologica (Roma) (01.07.2024)
Get full text
Journal Article
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial
Ferreri, Andrés J. M., Cwynarski, Kate, Pulczynski, Elisa, Fox, Christopher P., Schorb, Elisabeth, Celico, Claudia, Falautano, Monica, Nonis, Alessandro, La Rosée, Paul, Binder, Mascia, Fabbri, Alberto, Ilariucci, Fiorella, Krampera, Mauro, Roth, Alexander, Hemmaway, Claire, Johnson, Peter W., Linton, Kim M., Pukrop, Tobias, Gørløv, Jettes Sønderskov, Balzarotti, Monica, Hess, Georg, Keller, Ulrich, Stilgenbauer, Stephan, Panse, Jense, Tucci, Alessandra, Orsucci, Lorella, Pisani, Francesco, Zanni, Manuela, Krause, Stefan W., Schmoll, Hans J., Hertenstein, Bernd, Rummel, Mathias, Smith, Jeffery, Thurner, Lorenz, Cabras, Giuseppina, Pennese, Elsa, Ponzoni, Maurilio, Deckert, Martina, Politi, Letterio S., Finke, Jurgen, Ferranti, Antonella, Cozens, Kelly, Burger, Elvira, Ielmini, Nicoletta, Cavalli, Franco, Zucca, Emanuele, Illerhaus, Gerald
Published in Leukemia (01.07.2022)
Published in Leukemia (01.07.2022)
Get full text
Journal Article
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial
Ferreri, Andrés J M, Cwynarski, Kate, Pulczynski, Elisa, Fox, Christopher P, Schorb, Elisabeth, La Rosée, Paul, Binder, Mascha, Fabbri, Alberto, Torri, Valter, Minacapelli, Eleonora, Falautano, Monica, Ilariucci, Fiorella, Ambrosetti, Achille, Roth, Alexander, Hemmaway, Claire, Johnson, Peter, Linton, Kim M, Pukrop, Tobias, Sønderskov Gørløv, Jette, Balzarotti, Monica, Hess, Georg, Keller, Ulrich, Stilgenbauer, Stephan, Panse, Jens, Tucci, Alessandra, Orsucci, Lorella, Pisani, Francesco, Levis, Alessandro, Krause, Stefan W, Schmoll, Hans J, Hertenstein, Bernd, Rummel, Mathias, Smith, Jeffery, Pfreundschuh, Michael, Cabras, Giuseppina, Angrilli, Francesco, Ponzoni, Maurilio, Deckert, Martina, Politi, Letterio S, Finke, Jürgen, Reni, Michele, Cavalli, Franco, Zucca, Emanuele, Illerhaus, Gerald
Published in The Lancet. Haematology (01.11.2017)
Published in The Lancet. Haematology (01.11.2017)
Get more information
Journal Article
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial
Ferreri, Andrés J M, Cwynarski, Kate, Pulczynski, Elisa, Ponzoni, Maurilio, Deckert, Martina, Politi, Letterio S, Torri, Valter, Fox, Christopher P, Rosée, Paul La, Schorb, Elisabeth, Ambrosetti, Achille, Roth, Alexander, Hemmaway, Claire, Ferrari, Angela, Linton, Kim M, Rudà, Roberta, Binder, Mascha, Pukrop, Tobias, Balzarotti, Monica, Fabbri, Alberto, Johnson, Peter, Gørløv, Jette Sønderskov, Hess, Georg, Panse, Jens, Pisani, Francesco, Tucci, Alessandra, Stilgenbauer, Stephan, Hertenstein, Bernd, Keller, Ulrich, Krause, Stefan W, Levis, Alessandro, Schmoll, Hans J, Cavalli, Franco, Finke, Jürgen, Reni, Michele, Zucca, Emanuele, Illerhaus, Gerald
Published in The Lancet. Haematology (01.05.2016)
Published in The Lancet. Haematology (01.05.2016)
Get more information
Journal Article
Patients with Primary Central Nervous System Lymphoma Have High Levels of Soluble Programmed Cell Death Protein 1 in Their Pretherapeutic Cerebrospinal Fluid
Severinsen, Rasmus Svane Ditlev, Enemark, Marie Beck, Mortensen, Julie Bondgaard, Kjeldsen, Eigil, Thorsgaard, Michael, Pulczynski, Elisa Jacobsen, Oettingen, Gorm von, Møller, Holger Jon, Vejgaard, Christopher, Bjerre, Mette, d'Amore, Francesco
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Treatment of Patients with Relapsed or Refractory Primary CNS Lymphoma (rrPCNSL) Enrolled in the Randomized Trials of the International Extranodal Lymphoma Study Group (IELSG)
Ferreri, Andrés J M, Cwynarski, Kate, Pulczynski, Elisa, Fox, Christopher P., La Rosée, Paul, Schorb, Elisabeth, Krampera, Mauro, Ilariucci, Fiorella, Orsucci, Lorella, Fabbri, Alberto, Tucci, Alessandra, Roeth, Alexander, Linton, Kim, Binder, Mascha, Hemmaway, Claire, Cabras, Maria Giuseppina, Pinto, Antonio, Calimeri, Teresa, Cavalli, Franco, Zucca, Emanuele, Illerhaus, Gerald
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)
Illerhaus, Gerald, Ferreri, Andrés J.M., Binder, Mascha, Borchmann, Peter, Hasenkamp, Justin, Stilgenbauer, Stephan, Roeth, Alexander, Weber, Thomas, Egerer, Gerlinde, Ernst, Thomas, Hertenstein, Bernd, Lenz, Georg, Kobbe, Guido, Brunnberg, Uta, Schmidt, Christian, Kneba, Michael, Dreyling, Martin, Möhle, Robert, Panse, Jens, Heinicke, Thomas, Schroll, Sebastian, Larsen, Thomas S., Salwender, Hans, Naumann, Ralph, Hess, Georg, Thurner, Lorenz, Pukrop, Tobias, Keller, Ulrich, Blystadt, Anne Kirsti, Kroschinsky, Frank P., Re, Francesca, Pulczynski, Elisa, Orsucci, Lorella, Pospiech, Lisa, Deckert, Martina, Ponzoni, Maurilio, Wendler, Julia, Valk, Elke, Calimeri, Teresa, Kasenda, Benjamin, Trepel, Martin, Fricker, Heidi, von Gottberg, Philipp, Burger, Elvira, Ihorst, Gabriele, Grishina, Olga, Hader, Claudia, Zucca, Emanuele, Finke, Jürgen, Schorb, Elisabeth
Published in Blood (06.12.2022)
Published in Blood (06.12.2022)
Get full text
Journal Article
The Combination of Pixantrone, Etoposide, Bendamustine and, in CD20+ Tumors, Rituximab (PREBEN) Shows Promising Feasibility/Efficacy in Heavily Pre-Treated Aggressive Lymphomas of B- and T-Cell Phenotype - Results of the Pre-Trial Experience Leading to a Nordic Phase 1/2 Study (the PREBEN Trial)
Clausen, Michael Roost, Leppa, Sirpa, Brown, Peter de Nully, Goerloev, Jette Soenderskov, Panny, Michael, Willenbacher, Wolfgang, Sillesen, Ida Blok, Segel, Erik, Bentzen, Hans, Thorsgaard, Michael, Pulczynski, Elisa Jacobsen, Kamper, Peter, Gormsen, Lars C., Mortensen, Julie, Lauritzsen, Grethe, Relander, Thomas, d'Amore, Francesco
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase 2 study by The Nordic Lymphoma Group
Pulczynski, Elisa J, Kuittinen, Outi, Erlanson, Martin, Hagberg, Hans, Fosså, Alexander, Eriksson, Mikael, Nordstrøm, Marie, Ostenstad, Bjørn, Fluge, Oystein, Leppä, Sirpa, Fiirgaard, Bente, Bersvendsen, Hanne, Fagerli, Unn-Merete
Published in Haematologica (Roma) (2015)
Published in Haematologica (Roma) (2015)
Get full text
Journal Article
Preliminary Clinical Experience on the Efficacy and Feasibility of a New Combination Regimen Consisting of Pixantrone, Etoposide, and Bendamustine with or without the Addition of Rituximab in Patients with Relapsed/Refractory Aggressive Non-Hodgkin Lymphomas
d’Amore, Francesco, Joergensen, Judit, Sillesen, Ida Blok, Segel, Erik, Bentzen, Hans, Thorsgaard, Michael, Pulczynski, Elisa Jacobsen, Pedersen, Bjarne Bach, Gillström, Dorte, Clausen, Michael, Kamper, Peter, Silkjaer, Trine, Gormsen, Lars C., Leppä, Sirpa, Toldbod, Helle
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Effects on Survival and Neurocognitive Functions of Whole-Brain Radiotherapy (WBRT) and Autologous Stem Cell Transplantation (ASCT) as Consolidation Options after High-Dose Methotrexate-Based Chemoimmunotherapy in Patients with Newly Diagnosed Primary CNS Lymphoma (PCNSL): Results of the Second Randomization of the IELSG32 Trial
Ferreri, Andrés J.M., Cwynarski, Kate, Pulczynski, Elisa Jacobsen, Fox, Christopher P., Schorb, Elisabeth, La Rosée, Paul, Binder, Mascha, Fabbri, Alberto, Torri, Valter, Minacapelli, Eleonora, Falautano, Monica, Ilariucci, Fiorella, Ambrosetti, Achille, Röth, Alexander, Hemmaway, Claire Jane, Johnson, Peter M, Linton, Kim, Pukrop, Tobias, Sonderskov Gorlov, Jette, Balzarotti, Monica, Hess, Georg, Keller, Ulrich, Stilgenbauer, Stephan, Panse, Jens P., Tucci, Alessandra, Orsucci, Lorella, Pisani, Francesco, Levis, Alessandro, Krause, Stefan W., Schmoll, Hans-Joachim, Hertenstein, Bernd, Rummel, Mathias, Smith, Jeffery, Pfreundschuh, Michael, Cabras, Giuseppina, Angrilli, Francesco, Ponzoni, Maurilio, Deckert, Martina, Politi, Letterio S., Finke, Jurgen, Reni, Michele, Cavalli, Franco, Zucca, Emanuele, Illerhaus, Gerald
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Age-Adjusted Combined Immunochemotherapy without Radiotherapy in Newly Diagnosed PCNSL – A Phase II Trial of the Nordic Lymphoma Group
Pulczynski, Elisa Jacobsen, Kamper, Peter, Fagerli, Unn-Merete, Erlanson, Martin, Kuittinen, Outi, Fosså, Alexander, Østenstad, Bjørn, Fluge, Oystein, Maisenhølder, Martin, Hagberg, Hans, Eriksson, Mikael, Nordstrøm, Marie, Leppa, Sirpa
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
A phase III, randomized, controlled study evaluating the efficacy and safety of idelalisib (GS-1101) in combination with ofatumumab for previously treated chronic lymphocytic leukemia (CLL)
Flinn, Ian, Kimby, Eva, Cotter, Finbarr E., Giles, Francis J., Janssens, Ann, Pulczynski, Elisa Jacobsen, Ysebeart, Loic, Pluta, Andrzej, Garcia Marco, Jose Antonio, Taylor, Kerry, Owen, Carolyn, Johnson, David Michael, Aiello, Maria, Dansey, Roger D., Dubowy, Ronald L., Jones, Jeffrey Alan
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2013)
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2013)
Get full text
Journal Article
Conference Proceeding